Finassets Raises Affiliate Revenue, Tops Crypto Payouts
Finassets unveils a bold overhaul of its crypto affiliate program, boosting first-year partner earnings and locking i...
Wealth Accumulation Tips For Success
Looking to grow your wealth effectively? Explore valuable wealth accumulation tips for success and enhance your financial journey.
8,615 articlesStock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
This Hims & Hers Move Could Disrupt Competing Firms
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Freshworks CEO: Agile Enterprises Win the AI Race Right Now
Freshworks’ chief executive says agile, foundation-first transformation is driving AI wins for enterprises in 2026. T...
Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Redwire Contract Success Story Sparks Debate Ahead of Dip
Redwire’s backlog and contract wins are lifting the stock, but the company remains unprofitable. This report weighs t...
Wall Street Analyst Thinks Viking Stock Could Soar 188%
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
Johnson Johnson Just Paid a $1B Bet on Undruggable Target
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
Wall Street Expects This Growth Stock to Double Soon
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
Structure Therapeutics Stock 187% Gains: What It Means
Structure Therapeutics stock 187% gains over the last year drew attention from value seekers and momentum players ali...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status